Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?

BJU International

Volumn 97, Issue 1, 2006, Pages 51-55

  Haukaas, Svein A ^a,d   Halvorsen, Ole J ^b   Daehlin, Lars ^a   Hostmark, Jens ^c   Akslen, Lars A ^b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d Haraldsplass Deaconess Hospital   (Norway)

Author keywords

Prostate cancer progression; PSA; PSA doubling time; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; BIOCHEMISTRY; BONE METASTASIS; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HISTOLOGY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOME ASSESSMENT; PREDICTION; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RADICAL RETROPUBIC PROSTATECTOMY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SEMINAL VESICLE; STATISTICAL SIGNIFICANCE; SURVIVAL; TIME SERIES ANALYSIS; ARTICLE; BLOOD; BONE TUMOR; DISEASE FREE SURVIVAL; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREOPERATIVE CARE; PROSTATE TUMOR; PROSTATECTOMY; TUMOR RECURRENCE;

ADULT; AGED; BONE NEOPLASMS; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREOPERATIVE CARE; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 33644799333     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.05886.x     Document Type: Review

References (19)

1. Kupelian P Katcher J Levin H Zippe C Klein E Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy for clinically localised prostate cancer Urology 1996 48 249 60
2. Han M Partin AW Zahurak M Piantadosi S Epstein JI Walsh PC Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer J Urol 2003 169 517 23
3. Hull GW Rabbani F Abbas F Wheeler TM Kattan MW Scardino PT Cancer control with prostatectomy alone in 1,000 consecutive patients J Urol 2002 167 528 34
4. Stamey TA Johnstone IM McNeal JE Lu AY Yemoto CM Preoperative serum prostate specific antigen between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml J Urol 2002 167 103 11
5. Noguchi M Stamey TA McNeal JE Yemoto CM Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers J Urol 2000 164 1596 600
6. Djavan B Moul JW Zlotta A Remzi M Ravery V PSA progression following radical prostatectomy and radiation therapy: new standards in the new millennium Eur Urol 2003 43 12 27
7. Moul JW Prostate specific antigen only progression of prostate cancer J Urol 2000 163 632 42
8. Shinghal R Yemoto C McNeal JE Brooks JD Biochemical recurrence without PSA progression characterizes a subset of patients after radical prostatectomy Urology 2003 61 380 5
9. Ward JF Blute ML Slezak J Bergstralh EJ Zincke H The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy J Urol 2003 170 1872 6
10. Patel A Dorey F Franklin J deKernion JB Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen J Urol 1997 158 1441 5
11. Roberts SG Blute ML Bergstralh EJ Slezak JM Zincke H PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer Mayo Clin Proc 2001 76 576 81
12. D'Amico AV Whittington R Malkowicz SB et al. Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era J Urol 2001 166 2185 8
13. Jhaveri FM Zippe CD Klein EA Kupelian PA Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results Urology 1999 54 884 90
14. Pound CR Partin AW Eisenberger MA Chan DW Pearson JD Walsh PC Natural history of progression after PSA elevation following radical prostatectomy JAMA 1999 281 1591 7
15. Pruthi RS Johnstone I Tu IP Stamey TA Prostate-specific antigen doubling times in patients who have failed radical prostatectomy. correlation with histologic characteristics of the primary cancer Urology 1997 49 737 42
16. Cannon GM Walsh PC Partin AW Pound CR Prostate-specific antigen doubling time in the identification of patients at risk for progression after treatment and biochemical recurrence for prostate cancer Urology 2003 62 Suppl. 1 2 8
17. Parker CC Gospodarowicz M Warde P Does age influence the behavior of localized prostate cancer BJU Int 2001 87 629 37
18. Lu-Yao GL Yao SL Population based study of long-term survival in patients with clinically localised prostate cancer Lancet 1997 349 906 10
19. Barry MJ Albertsen PC Bagshaw MA et al. Outcomes for men with clinically non-metastatic prostate carcinoma managed with radical prostatectomy, external beam radiotherapy, or expectant management: a retrospective analysis Cancer 2001 91 2302 14